Mariner
VRTX icon

Mariner’s Vertex Pharmaceuticals VRTX Stock Holding History

Mariner’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$66.9M Buy
134,614
+3,014
+2% +$1.34M 0.07% 214
2026
Q1 		$58.8M Buy
131,600
+3,135
+2% +$1.46M 0.07% 237
2025
Q4 		$58.2M Buy
128,465
+18,214
+17% +$7.85M 0.07% 230
2025
Q3 		$43.2M Sell
110,251
-8,872
-7% -$3.71M 0.06% 269
2025
Q2 		$53M Buy
119,123
+2,562
+2% +$1.18M 0.08% 226
2025
Q1 		$56.5M Sell
116,561
-5,856
-5% -$2.73M 0.09% 194
2024
Q4 		$49.3M Sell
122,417
-1,077
-0.9% -$499K 0.08% 213
2024
Q3 		$57.4M Buy
123,494
+2,082
+2% +$1M 0.1% 188
2024
Q2 		$56.9M Buy
121,412
+5,951
+5% +$2.58M 0.11% 170
2024
Q1 		$48.3M Buy
115,461
+6,518
+6% +$2.76M 0.1% 197
2023
Q4 		$44.3M Buy
108,943
+12,331
+13% +$4.56M 0.11% 189
2023
Q3 		$33.6M Buy
96,612
+3,382
+4% +$1.18M 0.09% 205
2023
Q2 		$32.8M Buy
93,230
+1,828
+2% +$616K 0.09% 211
2023
Q1 		$28.8M Buy
91,402
+59,637
+188% +$17.9M 0.08% 223
2022
Q4 		$9.2M Buy
31,765
+13,022
+69% +$3.97M 0.03% 429
2022
Q3 		$5.43M Buy
18,743
+7,262
+63% +$2.09M 0.02% 488
2022
Q2 		$3.23M Buy
11,481
+460
+4% +$123K 0.01% 589
2022
Q1 		$2.88M Buy
+11,021
New +$2.62M 0.01% 630
2019
Q3 		– Sell
-1,302
Closed -$239K – 1050
2019
Q2 		$239K Buy
1,302
+39
+3% +$6.82K ﹤0.01% 975
2019
Q1 		$232K Buy
+1,263
New +$233K ﹤0.01% 915

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Mariner's VRTX Position: Q2 2026 in Review

Mariner increased its Vertex Pharmaceuticals (VRTX) stake by 2.3% in Q2 2026, buying an estimated $1.34M and bringing the position to 134,614 shares worth $66.9M. The position accounts for 0.07% of the portfolio, ranked #214.

Mariner first reported a position in VRTX in Q1 2019 and has held it in 20 quarters since. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Mariner held 134,614 shares of Vertex Pharmaceuticals worth $66.9M as of Q2 2026.
  • Mariner bought 3,014 Vertex Pharmaceuticals shares in Q2 2026, an estimated $1.34M.
  • Vertex Pharmaceuticals made up 0.07% of Mariner's portfolio in Q2 2026, its #214 holding.
  • Mariner first reported a position in Vertex Pharmaceuticals in Q1 2019 and has held it in 20 quarters since.
  • 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.